inherbin3

peptide antagonist of the ErbB1 receptor

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Berezin, Vladimir: 2 articles (12/2013 - 01/2010)
2.	Bock, Elisabeth: 2 articles (12/2013 - 01/2010)
3.	Xu, Ruodan: 2 articles (12/2013 - 01/2010)
4.	Christiansen, Søren Hofman: 1 article (12/2013)
5.	Højland, Anne: 1 article (12/2013)
6.	Pankratova, Stanislava: 1 article (12/2013)
7.	Woldbye, David: 1 article (12/2013)
8.	Povlsen, Gro Klitgaard: 1 article (01/2010)
9.	Soroka, Vladislav: 1 article (01/2010)

1.	Neoplasms (Cancer) 01/01/2010 - "Furthermore, we show that Inherbin3 inhibits tumor growth in vivo and induces apoptosis in a tumor xenograft model employing the human non-small cell lung cancer cell line A549. " 12/01/2013 - "We previously identified an ErbB1 peptide antagonist, Inherbin3, that is capable of inhibiting tumor growth in vitro and in vivo. " 01/01/2010 - "Moreover, the here described biological effects of Inherbin3 suggest that peptide-based targeting of ErbB receptor dimerization is a promising anti-cancer therapeutic strategy."
2.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/01/2010 - "Furthermore, we show that Inherbin3 inhibits tumor growth in vivo and induces apoptosis in a tumor xenograft model employing the human non-small cell lung cancer cell line A549. "